Last reviewed · How we verify
NCT05545267: SAVE
Monitoring of Dialysis Vascular Accesses During Angioplasty Under Echodoppler
trial testing Angioplasties in Arteriovenous Fistula Stenosis in 144 participants. Status unknown.
12 December 2021
Quick facts
| Lead sponsor | Centre Hospitalier de Vichy |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 144 |
| Start date | 17 September 2021 |
| Primary completion | 12 December 2021 |
| Estimated completion | 31 October 2022 |
| Sites | 1 location across France |
Drugs / interventions tested
- Angioplasties
Conditions studied
- Arteriovenous Fistula Stenosis — all drugs for Arteriovenous Fistula Stenosis →
Sponsor
Centre Hospitalier de Vichy
Who can join
18 and older, any sex, with Arteriovenous Fistula Stenosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Dialysis vascular accesses called arteriovenous fistulas ( AVF) are essential to ensure extra-renal purification by hemodialysis for patients with chronic end-stage renal disease. Complications of dialysis AVF cause significant morbidity and hospitalization. Dialysis AVF angioplasties are frequently used to treat stenosis, the 1st complication concerning them and which announces the complete thrombosis which may be the definitive loss of the AVF. Historically performed under X-ray, the progression in the quality of ultrasound scanners allows today to perform this procedure under echo-Doppler guidance and thus to avoid both radiation and the injection of iodinated contrast products and their complications. It is thus possible to preserve residual renal function, a situation with a better prognosis, or to help the maturation of the AVF without precipitating the patient towards dialysis. The procedure can then be less costly, requiring a much lighter infrastructure. The complication rates of ultrasound angioplasty remain poorly known because only a few series have been published. In addition, the evolution of the echo-Doppler parameters of the AVF is unknown during angioplasty and it is difficult to know which are the most reliable to distinguish during the procedure a "good angioplasty gesture" from an incomplete angioplasty to be continued. The proposed study would provide initial insight into the question posed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05545267
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Arteriovenous Fistula Stenosis
Currently open trials in the same condition.
- NCT06639451 — A Prospective, Multi-center Study to Evaluate Efficacy and Safety of BSJ020R in Treatment of AVF for Hemodialysis (RANGE · NA · active not recruiting
- NCT06553443 — Randomised Clinical Trial Comparing Drug-coated Balloon to Plain Balloon for All Peripheral AVF Stenosis · Phase 3 · recruiting
Other Centre Hospitalier de Vichy trials
Trials by the same sponsor.
- NCT06692231 — Impact of Hospital Pharmacist Intervention on Medication Management in Dialysis Patients · NA · not yet recruiting
- NCT04102527 — Evaluation of the Impact of Transit Troubles in Patients Undergoing Peritoneal Dialysis · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05545267 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier de Vichy
- Last refreshed: 19 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05545267.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing